Loading headlines…

Collected headline brief
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering…
Complete reading on newsGlobal
Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →There is more to this story